Seth T. Gammon, Ph.D. - Publications

2007 Washington University, Saint Louis, St. Louis, MO 
Molecular Biology, Radiology

5 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 Gammon S, Paoli P, Powell E, Piwnca-Worms D, Piwinca-Worms H, Machetti F, Brandi A, Cicchi S, Biagiotti G, Pisanesch F. Labeling of a drug delivery system based on carbon nanotubes with 68Ga and 64Cu: an in vivo biodistribution study Nuclear Medicine and Biology. DOI: 10.1016/S0969-8051(19)30297-5  0.36
2016 Lin Y, Millward S, Gammon S, Satani N, Hammoudi N, Gray JP, Kelderhouse LE, Ornelas A, Schroeder H, Muller FL. Abstract 4242: Rhodamine esters as fluorescent tumor painting agents for glioblastoma Cancer Research. 76: 4242-4242. DOI: 10.1158/1538-7445.Am2016-4242  0.36
2016 Kelderhouse LE, Hardy A, Pisaneschi F, Gray JP, Gammon S, Roberts RW, Takahashi TT, Fiacco S, Millward SW. Abstract 4236: SUPR-PET: Nuclear imaging of Her2-positieve breast cancer with SUPR peptides Cancer Research. 76: 4236-4236. DOI: 10.1158/1538-7445.Am2016-4236  0.36
2015 Kelderhouse LE, Hardy A, Pan Y, Rhea P, Ornelas A, Gammon S, Yang P, Fiacco S, Millward SW. Abstract P5-01-10: In vitro and in vivo imaging of Her2 with cyclic peptides derived from directed evolution Cancer Research. 75. DOI: 10.1158/1538-7445.Sabcs14-P5-01-10  0.36
2015 Kelderhouse L, Hardy A, Takahashi TT, Ornelas A, Gammon S, Howell S, Yang P, Wang P, Roberts RW, Fiacco S, Millward SW. Abstract 1499: SUPR peptides as novel targeted molecular imaging agents for Her2 Cancer Research. 75: 1499-1499. DOI: 10.1158/1538-7445.Am2015-1499  0.36
Show low-probability matches.